Department of Global Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Health Policy and Management, School of Medicine, Keio University, Tokyo, Japan.
Global Health. 2020 Apr 15;16(1):32. doi: 10.1186/s12992-020-00559-2.
Development assistance for health (DAH) is one of the most important means for Japan to promote diplomacy with developing countries and contribute to the international community. This study, for the first time, estimated the gross disbursement of Japan's DAH from 2012 to 2016 and clarified its flows, including source, aid type, channel, target region, and target health focus area.
Data on Japan Tracker, the first data platform of Japan's DAH, were used. The DAH definition was based on the Organisation for Economic Co-operation and Development's (OECD) sector classification. Regarding core funding to non-health-specific multilateral agencies, we estimated DAH and its flows based on the OECD methodology for calculating imputed multilateral official development assistance (ODA).
Japan's DAH was estimated at 1472.94 (2012), 823.15 (2013), 832.06 (2014), 701.98 (2015), and 894.57 million USD (2016) in constant prices of 2016. Multilateral agencies received the largest DAH share of 44.96-57.01% in these periods, followed by bilateral grants (34.59-53.08%) and bilateral loans (1.96-15.04%). Ministry of Foreign Affairs (MOFA) was the largest contributors to the DAH (76.26-82.68%), followed by Ministry of Finance (MOF) (10.86-16.25%). Japan's DAH was most heavily distributed in the African region with 41.64-53.48% share. The channel through which the most DAH went was Global Fund to Fight AIDS, Tuberculosis, and Malaria (20.04-34.89%). Between 2012 and 2016, approximately 70% was allocated to primary health care and the rest to health system strengthening.
With many major high-level health related meetings ahead, coming years will play a powerful opportunity to reevaluate DAH and shape the future of DAH for Japan. We hope that the results of this study will enhance the social debate for and contribute to the implementation of Japan's DAH with a more efficient and effective strategy.
卫生发展援助(DAH)是日本促进与发展中国家外交关系、为国际社会做贡献的最重要手段之一。本研究首次估算了日本 2012 年至 2016 年 DAH 的总支出,并阐明了其流向,包括来源、援助类型、渠道、目标地区和目标卫生重点领域。
使用日本发展援助跟踪器(Japan Tracker)的第一个日本 DAH 数据平台。DAH 的定义基于经济合作与发展组织(OECD)的部门分类。对于向非特定于卫生的多边机构的核心供资,我们根据 OECD 计算推算多边官方发展援助(ODA)的方法,估算了 DAH 及其流向。
按 2016 年不变价格计算,日本 DAH 分别为 2012 年 147.294 亿美元、2013 年 82.315 亿美元、2014 年 83.206 亿美元、2015 年 701.984 亿美元和 2016 年 894.574 亿美元。在此期间,多边机构接收的 DAH 份额最大,为 44.96-57.01%,其次是双边赠款(34.59-53.08%)和双边贷款(1.96-15.04%)。外务省(MOFA)是 DAH 的最大贡献者(76.26-82.68%),其次是财务省(MOF)(10.86-16.25%)。日本 DAH 主要分布在非洲地区,占比 41.64-53.48%。DAH 最多的渠道是全球抗击艾滋病、结核病和疟疾基金(20.04-34.89%)。2012 年至 2016 年间,约 70%用于初级卫生保健,其余用于加强卫生系统。
随着未来几年将举行许多重大高级别卫生相关会议,这将是一个重新评估 DAH 并为日本 DAH 的未来塑造蓝图的强大机会。我们希望本研究的结果将加强社会辩论,并为实施日本 DAH 提供更有效和高效的战略做出贡献。